2 FTSE 100 dividend stocks I’d aim to never sell

I wouldn’t try to hold all my investments forever, but these two FTSE 100 dividend stocks both have many qualities that mean I’d like to keep them long term.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I wouldn’t try to hold every single one of my investments forever. But there are at least a few FTSE 100 dividend stocks I’d aim to never sell.

Growth driven by the R&D pipeline

For example, pharmaceutical company AstraZeneca (LSE: AZN) strikes me as being a top-quality business operating in an attractive sector. And at the end of July, the company said in its interim results report that it’s “accelerating top-line growth with continued pipeline progress”.

Indeed, the Research & Development (R&D) pipeline has offered plenty of potential for a number of years. But lately, the firm’s Regulatory News Service (RNS) feed has been vibrant with positive announcements.

AstraZeneca reckons the way the pipeline has been spitting out new cash-earning treatments and medicines “underpins the transition to long-term sustainable growth”. And there was a high-profile example of the capabilities of the business recently when it produced its Covid-19 vaccine and gave it to the world at cost price.

Meanwhile, with the share price near 8,635p, the forward-looking dividend yield for 2022 is around 2.4%. That’s not the highest FTSE 100 yield available. But I think the business is capable of driving increases in the years ahead. But, of course, as with all companies and stocks, there’s potential for setbacks as well as successes in the future. Nevertheless, I’d be inclined to focus on the quality of the enterprise and aim to hold some of the shares through thick and thin, way into the future.

A great sector for enduring FTSE 100 dividend stocks

And alongside AstraZeneca, I’d target Unilever (LSE: ULVR), the fast-moving consumer goods giant.

I think the branded consumable goods sector is a decent place to hunt for enduring investments. In theory, companies operating in the sector tend to generate stable cash inflow whatever the economy is doing. And I think that happens because people like to keep buying their favourite food, cleaning and other staples no matter how tough things become for them financially.

And Unilever is a London-listed behemoth in the sector. It has a long record of trading and financial success, driven by its well-loved brands such as Cif, Domestos, Hellman’s, Marmite and many others.

In July’s interim results report, chief executive Alan Jope said the company is making “good progress” developing the product portfolio into “high growth spaces”. Of course, nothing is certain, but I’m expecting Unilever to increase its shareholder dividends and its earnings by a modest, single-digit percentage each year. And if it doesn’t, and even if the share price declines and I lose money on paper, I’ll likely keep holding on to my stock.

Now, with the share price near 3,809p, the forward-looking dividend yield is around 3.3% for 2022. Again, that’s not the highest yield in the FTSE 100. But I like the way the firm’s consistent cash inflow backs up the shareholder payment.

I’m not guaranteed a positive investment outcome just because I like these two stocks now. Things can go wrong in both underlying businesses — all shares carry risks. But these are two FTSE 100 dividend stocks I’d aim to never sell.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has recommended Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

1 FTSE dividend stock I’d put 100% of my money into for passive income!

If I could invest in just one stock to generate a regular passive income stream, I'd choose this FTSE 100…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

Forecasts are down, but I see a bright future for FTSE 100 dividend stocks

Cash forecasts for UK dividend stocks are falling... time to panic! Actually, no. I reckon the future has never looked…

Read more »

Young female analyst working at her desk in the office
Investing Articles

Down 13% in April, AIM stock YouGov now looks like a top-notch bargain

YouGov is an AIM stock that has fallen into potential bargain territory. Its vast quantity of data sets it up…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Beating the S&P 500? I’d buy this FTSE 250 stock for my Stocks and Shares ISA

Beating the S&P 500's tricky, but Paul Summers is optimistic on this FTSE 250 stock's ability to deliver based on…

Read more »

Passive and Active: text from letters of the wooden alphabet on a green chalk board
Investing Articles

2 spectacular passive income stocks I’d feel confident going all in on

While it's true that diversification is key when it comes to safe and reliable investing, these two passive income stocks…

Read more »

Investing Articles

The easyJet share price is taking off. I think it could soar!

The easyJet share price is having a very good day. Paul Summers takes a look at the latest trading update…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

9 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

As the Rentokil share price dips on Q1 news, I ask if it’s time to buy

The Rentokil Initial share price has disappointed investors in the past 12 months. Could this be the year we get…

Read more »